Quick Dispatch:
Your glp-1 antagonists GLP-1R, GIPR, and GCGR: Targets for Obesity and Diabetes orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 antagonists GLP-1R, GIPR, and GCGR: Targets for Obesity and Diabetes ships.
Need Help?
Questions about glp-1 antagonists GLP-1R, GIPR, and GCGR: Targets for Obesity and Diabetes, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 antagonists GLP-1R, GIPR, and GCGR: Targets for Obesity and Diabetes in your area.
Understanding GLP-1 receptor agonists and their impact on drug discovery
21.16
Frontiers
24.81
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports
22.69
What is GLP-1 and Its Receptor Agonists?
27.72
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
27.78
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
24.32
Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R/GIPR biased agonism yielding greater efficacy: Cell Reports Medicine
22.32
